The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations?

Anthony Gonçalves; Audrey Monneur; Patrice Viens; François Bertucci

doi:10.1080/14737140.2017.1330655

Journal Articles Expert Review of Anticancer Therapy Year : 2017

The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations?

(1) , (2) , (1) , (3)

1
2
3

Anthony Gonçalves

Function : Author
PersonId : 791165
ORCID : 0000-0001-7570-7439

Institut Paoli-Calmettes

Audrey Monneur

Function : Author

Département d’Oncologie Médicale [IPC, Marseille]

Patrice Viens

Function : Author

Institut Paoli-Calmettes

François Bertucci

Function : Author
PersonId : 753650
IdHAL : francois-bertucci
ORCID : 0000-0002-0157-0959

Centre de Recherche en Cancérologie de Marseille

CV

Domains

Life Sciences [q-bio] Cancer

François Bertucci : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-03623715

Submitted on : Tuesday, March 29, 2022-6:42:33 PM

Last modification on : Wednesday, March 30, 2022-3:59:57 AM

Dates and versions

hal-03623715 , version 1 (29-03-2022)

Identifiers

HAL Id : hal-03623715 , version 1
DOI : 10.1080/14737140.2017.1330655

Cite

Anthony Gonçalves, Audrey Monneur, Patrice Viens, François Bertucci. The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations?. Expert Review of Anticancer Therapy, 2017, 17 (7), pp.593-606. ⟨10.1080/14737140.2017.1330655⟩. ⟨hal-03623715⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

CNRS UNIV-AMU CRCM

5 View

0 Download

The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations?

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share